NO135054B - - Google Patents
Download PDFInfo
- Publication number
- NO135054B NO135054B NO743751A NO743751A NO135054B NO 135054 B NO135054 B NO 135054B NO 743751 A NO743751 A NO 743751A NO 743751 A NO743751 A NO 743751A NO 135054 B NO135054 B NO 135054B
- Authority
- NO
- Norway
- Prior art keywords
- nitrofurantoin
- methanol
- approx
- crystals
- sodium
- Prior art date
Links
- 229960000564 nitrofurantoin Drugs 0.000 claims description 19
- NXFQHRVNIOXGAQ-YCRREMRBSA-N nitrofurantoin Chemical class O1C([N+](=O)[O-])=CC=C1\C=N\N1C(=O)NC(=O)C1 NXFQHRVNIOXGAQ-YCRREMRBSA-N 0.000 claims description 19
- 150000003839 salts Chemical class 0.000 claims description 11
- 239000000725 suspension Substances 0.000 claims description 9
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical group [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 8
- 229910052700 potassium Chemical group 0.000 claims description 8
- 239000011591 potassium Chemical group 0.000 claims description 8
- 239000007788 liquid Substances 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 6
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical group C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 5
- 229910052708 sodium Inorganic materials 0.000 claims description 5
- 239000011734 sodium Substances 0.000 claims description 5
- 150000004703 alkoxides Chemical class 0.000 claims description 4
- 239000012736 aqueous medium Substances 0.000 claims description 2
- 239000002609 medium Substances 0.000 claims description 2
- 230000000973 chemotherapeutic effect Effects 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 claims 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 57
- 239000013078 crystal Substances 0.000 description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- 239000000203 mixture Substances 0.000 description 10
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 239000000243 solution Substances 0.000 description 8
- 238000003756 stirring Methods 0.000 description 7
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 229910052783 alkali metal Inorganic materials 0.000 description 6
- -1 alkali metal salts Chemical class 0.000 description 5
- 238000001035 drying Methods 0.000 description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000012429 reaction media Substances 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
- 239000002246 antineoplastic agent Substances 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- 229940127089 cytotoxic agent Drugs 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000003182 parenteral nutrition solution Substances 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000008156 Ringer's lactate solution Substances 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000013058 crude material Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 150000004679 hydroxides Chemical class 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- IAIWVQXQOWNYOU-FPYGCLRLSA-N nitrofural Chemical compound NC(=O)N\N=C\C1=CC=C([N+]([O-])=O)O1 IAIWVQXQOWNYOU-FPYGCLRLSA-N 0.000 description 1
- 229960001907 nitrofurazone Drugs 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000013557 residual solvent Substances 0.000 description 1
- 239000010802 sludge Substances 0.000 description 1
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Ropes Or Cables (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NO743751A NO135054B (xx) | 1974-10-17 | 1974-10-17 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NO743751A NO135054B (xx) | 1974-10-17 | 1974-10-17 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO743751L NO743751L (xx) | 1975-06-30 |
| NO135054B true NO135054B (xx) | 1976-10-25 |
Family
ID=19881886
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO743751A NO135054B (xx) | 1974-10-17 | 1974-10-17 |
Country Status (1)
| Country | Link |
|---|---|
| NO (1) | NO135054B (xx) |
-
1974
- 1974-10-17 NO NO743751A patent/NO135054B/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO743751L (xx) | 1975-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4355043A (en) | Novel derivatives of 3-aminopropanesulfonic acid having a reinforced activity on membrane | |
| DE2845496A1 (de) | N hoch 2 -substituierte phenyl-2,6- diaminonebularine und sie enthaltende arzneimittelzubereitungen | |
| CA2614545A1 (en) | Choline salt crystal of azulene compound | |
| US3703542A (en) | Hydroxamic acid derivatives of 1-amino-cyclohexanecarboxylic acid | |
| US3814812A (en) | Medicament and method of increasing the calcium content of the blood | |
| WO2022247065A1 (zh) | 己酮可可碱的合成方法 | |
| NO135054B (xx) | ||
| US3007846A (en) | Alkali metal salts of nitrofurantoin | |
| Smith et al. | A Reinvestigation of the Preparation of β-Methyl Lactoside1, 2 | |
| Tipson et al. | Reinvestigation of alloxantin and dialuric acid | |
| SU1493101A3 (ru) | Способ получени п-аминофенола или его производных | |
| US2569288A (en) | Preparation of n-benzyl-betahalopropionamides | |
| Heymann et al. | Derivatives of p, p'-Diaminodiphenyl Sulfone1a | |
| US955587A (en) | New purin bases. | |
| US9834540B2 (en) | Omeprazole Sodium semihydrate and preparation method thereof | |
| NO117505B (xx) | ||
| Agrawal | Fluorene derivatives for antitumor activity | |
| CN112939864B (zh) | 螺[苯并[c]氮杂-1,1’-环己基]-3-酮类化合物 | |
| NO133892B (xx) | ||
| US2654753A (en) | 2-sulfanilamido-5-aminopyrimidine and salts thereof | |
| JPS6026386B2 (ja) | 新規イソインド−ル化合物 | |
| EP0235514A1 (en) | New N-typed crystals of calcium gluconate | |
| US2404199A (en) | 2-sulphanilamido-quinoxaline | |
| CN107857756B (zh) | 一种艾普拉唑镁晶型及其制备方法 | |
| RU2294324C1 (ru) | Натриевая соль n-хлорацетил-5-бромантраниловой кислоты, проявляющая гемостатическое действие |